thymidine | CAS:50-89-5

We serve thymidine CAS:50-89-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
thymidine

Chemical Name:thymidine
CAS.NO:50-89-5
Synonyms:THYMIDINE
2,4(1H,3H)-Pyrimidinedione,1-(2-deoxy-Beta-D-erythro-pentofuranosyl)-5-methyl
2'-dT
2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-β-D-erythro-pentofuranosyl)-5-methyl
Molecular Formula:C10H14N2O5
Molecular Weight:242.22900
 
Physical and Chemical Properties:
Density:1.452
Melting point:187-189ºC
Index of Refraction:1.584
 
Specification:
Appearance:White to off-white crystalline powder
Assay(HPLC):≥99.0%
Loss on drying:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Zidovudine.



Contact us for information like THYMIDINE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-β-D-erythro-pentofuranosyl)-5-methyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2′-dT Use and application,2,4(1H,3H)-Pyrimidinedione,1-(2-deoxy-Beta-D-erythro-pentofuranosyl)-5-methyl technical grade,usp/ep/jp grade.


Related News: According to the business type, it can be divided into non-CMO business of APIs and intermediates and CMO business of APIs and intermediates.1-Chloro-5-iodopentane manufacturer According to the business type, it can be divided into non-CMO business of APIs and intermediates and CMO business of APIs and intermediates.3-Aminophthalic acid supplier Also that day the CDC reported the first case of person-to-person transmission in Illinois between household members.3,5-Dimethylbenzoic acid vendor Also that day the CDC reported the first case of person-to-person transmission in Illinois between household members.Dr. John K. Westwick, CEO of Resonant, added “Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.